Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
Open Access
- 1 July 1982
- Vol. 23 (7) , 621-624
- https://doi.org/10.1136/gut.23.7.621
Abstract
Fifty patients with endoscopically proven gastric ulcers completed a 1-mo. double-blind randomized trial of tripotassium dicitrato bismuthate (TDB) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in 9 (36%) of the patients given the placebo. The TDB group experienced significantly less pain than the placebo group. During a follow-up of 29 patients with healed ulcers for up to 44 mo., relapse occurred in 13 (45%). It was highest in the first 3 mo. (27%) and had risen to 41% at 2 yr.This publication has 16 references indexed in Scilit:
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981
- Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.Gut, 1980
- Double-blind controlled trial of cimetidine in the healing of gastric ulcer.Gut, 1979
- Cimetidine: an advance in gastric ulcer treatment?BMJ, 1978
- INCREASED HEALING OF GASTRIC AND DUODENAL ULCERS IN A CONTROLLED TRIAL USING TRIPOTASSIUM DICITRATO‐BISMUTHATEThe Medical Journal of Australia, 1977
- A double-blind gastroscopic study of a bismuth-peptide complex in gastric ulceration.1974
- The Veterans Administration Cooperative Study on Gastric Ulcer. 4. The follow-up period.1971
- Double blind trial of naphthypramide (DA-992) in osteoarthritis.1970
- Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.Gut, 1965
- CLINICAL TRIAL OF A TRITERPENOID LIQUORICE COMPOUND IN GASTRIC AND DUODENAL ULCERThe Lancet, 1962